Announcing the Olink® Target 48 Mouse Cytokine Panel – the next generation in immunoassays designed to accelerate translational research.
19 sept. 2023 03h00 HE
|
Olink Proteomics AB
Uppsala, Sweden, Sept. 19, 2023 (GLOBE NEWSWIRE) -- Announcing the Olink® Target 48 Mouse Cytokine Panel – the next generation in immunoassays designed to accelerate translational research. ...
Eurofins Genomics adopts Olink® technology to advance proteomics research and accelerate precision medicine programs
12 sept. 2023 11h00 HE
|
Olink Proteomics AB
Uppsala, Sweden, Sept. 12, 2023 (GLOBE NEWSWIRE) -- Eurofins Genomics adopts Olink® technology to advance proteomics research and accelerate precision medicine programs UPPSALA, Sweden, 12th...
Olink to participate in September investor events
29 août 2023 08h00 HE
|
Olink Proteomics AB
UPPSALA, Sweden, Aug. 29, 2023 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK), today announced that Company management will participate in the following investor events: ...
Olink reports second quarter 2023 financial results
09 août 2023 07h00 HE
|
Olink Proteomics AB
UPPSALA, Sweden, Aug. 09, 2023 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK) today announced its unaudited financial results for the second quarter ended June 30, 2023. ...
Baylor College of Medicine Human Genome Sequencing Center adopts Olink® Explore HT proteomics platform
08 août 2023 08h00 HE
|
Olink Proteomics AB
UPPSALA, Sweden, Aug. 08, 2023 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK) today announced that the Baylor College of Medicine Human Genome Sequencing Center (BCM-HGSC) has...
Olink to report second quarter 2023 financial results on August 9, 2023, and to participate in the Canaccord Genuity 43rd Annual Growth Conference
13 juil. 2023 08h00 HE
|
Olink Proteomics AB
UPPSALA, Sweden, July 13, 2023 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK) today announced it will release financial results for the second quarter of 2023 before the market...
Olink to report second quarter 2023 financial results on August 9, 2023, and to participate in the Canaccord Genuity 43rd Annual Growth Conference
13 juil. 2023 08h00 HE
|
Olink Proteomics AB
UPPSALA, Sweden, July 13, 2023 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK) today announced it will release financial results for the second quarter of 2023 before the market...
Announcing Olink® Explore HT – A New Era in Proteomics
12 juil. 2023 09h00 HE
|
Olink Proteomics AB
UPPSALA, Sweden, July 12, 2023 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (Nasdaq: OLK) today announced the introduction of Olink® Explore HT, a transformational solution for high-throughput...
Revealing the secrets of the human proteome with Olink® Insight: Exploring findings from one of the world's largest health studies
28 juin 2023 08h00 HE
|
Olink Proteomics AB
UPPSALA, Sweden, June 28, 2023 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (Nasdaq: OLK) today announced the availability of new findings into the variability of the human proteome, based on...
Revealing the secrets of the human proteome with Olink® Insight: Exploring findings from one of the world's largest health studies
28 juin 2023 08h00 HE
|
Olink Proteomics AB
Uppsala, Sweden, June 28, 2023 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (Nasdaq: OLK) today announced the availability of new findings into the variability of the human proteome, based on...